SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-17-000853
Filing Date
2017-10-02
Accepted
2017-10-02 17:20:11
Documents
2
Period of Report
2017-09-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT cymabaytherafm4_10217.html 4  
1 OWNERSHIP DOCUMENT cymabaytherafm4_10217.xml 4 8859
2 KURT VON EMSTER POWER OF ATTORNEY vonemster_poaoct2017.htm EX-99 6691
  Complete submission text file 0000905718-17-000853.txt   17122
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 GATEWAY BOULEVARD SUITE 350 SAN FRANCISCO CA 94080
Business Address
EMSTER KURT VON (Reporting) CIK: 0001252524 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36500 | Film No.: 171115379